JESSICA BARTHOLOMEW: Open Payments
NPI 1639732274 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,248 in 56 payments from 9 companies in 2025. Trend: 2023 $1,718 · 2024 $1,040 · 2025 $9,248
Speaker / faculty: $5,008Food & beverage: $1,524Consulting: $1,155Travel & lodging: $1,029Grant: $500Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $7,581 |
| Madrigal Pharmaceuticals | 12 | $926 |
| Gilead Sciences, Inc. | 11 | $247 |
| Ipsen Biopharmaceuticals, Inc | 7 | $163 |
| ABBVIE INC. | 10 | $142 |
| ORPHALAN INC | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $47 |
| Fujifilm Healthcare Americas Corporation | 1 | $30 |
| Medtronic, Inc. | 1 | $19 |
Products named: Wegovy, REZDIFFRA, IQIRVO, CUVRIOR, RINVOQ, SKYRIZI, UTASWAKO AFP-L3, VIBERZI.
Industry payments across TX — which companies pay providers there.
